Preventing Physical and Emotional Violence by Parents and Teachers in Public Schools in Tanzania (ICC-T/ICC-P_Tanz)
Launched by BIELEFELD UNIVERSITY · Apr 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the ICC-T/ICC-P_Tanz, is focused on reducing violence against children in their homes and schools in Tanzania. The aim is to test a new program that helps both parents and teachers learn how to prevent physical and emotional violence. This is important because many children around the world, particularly in Africa, face violence that can harm their development and well-being. The trial will evaluate how well this program works, how acceptable it is to families and schools, and whether it is cost-effective.
To participate in this study, students aged 9 to 13 must be enrolled in selected public primary schools, and their parents or caregivers must also be involved. Teachers working at these schools and aged between 18 and 60 can participate as well. Participants can expect to engage in activities aimed at learning better ways to support and care for children, ultimately helping to create a safer environment for them. If you are interested in joining or want to learn more, please check if you meet the eligibility criteria and consider discussing it with your family or school representatives.
Gender
ALL
Eligibility criteria
- General:
- Inclusion Criteria:
- Schools:
- • Public primary schools
- • at least 45 students in selected class/ stream
- • least 25 but no more than 50 employed teacher in selected school.
- All participants:
- • - Written informed consent (if underaged by parents (written) \& minors themselves (orally)
- Students:
- • Enrollment in selected public primary school, age between 9 and 13 years
- • living with their caregiver or parents near to the schools
- Teachers:
- • employed at the selected schools
- • aged between 18 and 60 years of age (statutory retirement age)
- Parents:
- • their child is participating in the study and is enrolled in a study's eligible school,
- • social parent (the parent currently taking care of the child independent of the biological relationship to the children; social parents can be biological parents, step-parents, foster parents, relatives, etc.)
- • aged between 16 and 80 years of age
- Exclusion criteria (all participants):
- • Acute drug or alcohol intoxication,
- • acute psychotic disorder
- • severe mental disabilities
About Bielefeld University
Bielefeld University is a leading research institution in Germany, renowned for its interdisciplinary approach and commitment to advancing knowledge across various fields, including health sciences. The university actively engages in innovative clinical trials aimed at improving patient outcomes and enhancing medical practices. With a robust framework for research ethics and a focus on collaboration, Bielefeld University fosters an environment that promotes scientific excellence and contributes to the global understanding of health-related issues. Through its clinical trial initiatives, the university aims to translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Daressalam, , Tanzania
Patients applied
Trial Officials
Tobias Hecker, Prof. Dr.
Principal Investigator
Bielefeld University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported